Advisory Council for the Elimination of Tuberculosis Meeting (ACET), 55172 [2018-23974]
Download as PDF
<![CDATA[
55172
Federal Register / Vol. 83, No. 213 / Friday, November 2, 2018 / Notices
the causes, diagnosis, treatment, control,
and prevention of physical and mental
diseases, and other impairments; (2)
assist States and their political
subdivisions in preventing and
suppressing communicable and noncommunicable diseases and other
preventable conditions and in
promoting health and well-being; and
(3) conduct and assist in research and
control activities related to injury. The
Board of Scientific Counselors makes
recommendations regarding policies,
strategies, objectives, and priorities; and
reviews progress toward injury
prevention goals and provides evidence
in injury prevention-related research
and programs. The Board also provides
advice on the appropriate balance of
intramural and extramural research, the
structure, progress and performance of
intramural programs. The Board is
designed to provide guidance on
extramural scientific program matters,
including the: (1) Review of extramural
research concepts for funding
opportunity announcements; (2)
conduct of Secondary Peer Review of
extramural research grants, cooperative
agreements, and contracts applications
received in response to the funding
opportunity announcements as it relates
to the Center’s programmatic balance
and mission; (3) submission of
secondary review recommendations to
the Center Director of applications to be
considered for funding support; (4)
review of research portfolios, and (5)
review of program proposals.
Matters to be Considered: The Board
of Scientific Counselors will discuss
science matters to include research
strategies needed to guide the Center’s
focus on reducing opioid overdose and
to review the recommendations from the
opioid prescribing for acute and chronic
pain workgroup. Agenda items are
subject to change as priorities dictate.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2018–23976 Filed 11–1–18; 8:45 am]
BILLING CODE 4163–19–P
VerDate Sep<11>2014
17:57 Nov 01, 2018
Jkt 247001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Council for the Elimination of
Tuberculosis Meeting (ACET)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
of the Advisory Council for the
Elimination of Tuberculosis Meeting
(ACET). This meeting is open to the
public, limited only by the space
available. The meeting room
accommodates approximately 80 people
and has 100 ports for audio phone lines.
Time will be available for public
comment. The public is welcome to
submit written comments in advance of
the meeting. Comments should be
submitted in writing by email to the
contact person listed below. The
deadline for receipt is Monday,
December 10, 2018. Persons who desire
to make an oral statement, may request
it at the time of the public comment
period on December 12, 2018 at 11:40
a.m., EST.
DATES: The meeting will be held on
December 11, 2018, 8:30 a.m. to 4:30
p.m., EST and December 12, 2018, 8:30
a.m. to 12:00 p.m., EST.
ADDRESSES: 8 Corporate Blvd., Building
8, Conference Rooms 1–A/B/C, Atlanta,
Georgia, 30329 and Web conference: 1–
877–927–1433 and participant
passcode: 12016435 and https://
adobeconnect.cdc.gov/r5p8l2tytpq/.
FOR FURTHER INFORMATION CONTACT:
Margie Scott-Cseh, Committee
Management Specialist, CDC, 1600
Clifton Road, NE, Mailstop: E–07,
Atlanta, Georgia, 30333, telephone (404)
639–8317; zkr7@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: This Council advises and
makes recommendations to the
Secretary of Health and Human
Services, the Assistant Secretary for
Health, and the Director, CDC, regarding
the elimination of tuberculosis.
Specifically, the Council makes
recommendations regarding policies,
strategies, objectives, and priorities;
addresses the development and
application of new technologies; and
reviews the extent to which progress has
been made toward eliminating
tuberculosis.
Matters to be Considered: The agenda
will include discussions on (1) Division
SUMMARY:
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
of Tuberculosis Elimination (DTBE)
funded Demonstration Project on Latent
Tuberculosis Infection (LTBI) Testing
and Treatment; (2) DTBE
Communications Messaging and
Campaigns; (3) Update on LTBI
Treatment Guidelines; (4) Update on
Drug Resistant Tuberculosis Guidelines;
and (5) Update from ACET workgroups.
Agenda items are subject to change as
priorities dictate.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2018–23974 Filed 11–1–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3371–PN]
Medicare and Medicaid Programs:
Accreditation Commission for Health
Care, Inc (ACHC) for Approval of its
End Stage Renal Disease (ESRD)
Facility Accreditation Program
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice with request for
comment.
AGENCY:
This proposed notice
acknowledges the receipt of an
application from the Accreditation
Commission for Health Care, Inc., for
recognition as a national accrediting
organization for End Stage Renal
Disease Facilities that wish to
participate in the Medicare or Medicaid
programs.
DATES: To be assured consideration,
comments must be received at one of
the addresses provided below, no later
than 5 p.m. on December 3, 2018.
ADDRESSES: In commenting, refer to file
code CMS–3371–PN. Because of staff
and resource limitations, we cannot
accept comments by facsimile (FAX)
transmission.
Comments, including mass comment
submissions, must be submitted in one
of the following three ways (please
choose only one of the ways listed):
SUMMARY:
E:\FR\FM\02NON1.SGM
02NON1
]]>Agencies
[Federal Register Volume 83, Number 213 (Friday, November 2, 2018)]
[Notices]
[Page 55172]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-23974]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Council for the Elimination of Tuberculosis Meeting
(ACET)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting of the Advisory Council for the
Elimination of Tuberculosis Meeting (ACET). This meeting is open to the
public, limited only by the space available. The meeting room
accommodates approximately 80 people and has 100 ports for audio phone
lines. Time will be available for public comment. The public is welcome
to submit written comments in advance of the meeting. Comments should
be submitted in writing by email to the contact person listed below.
The deadline for receipt is Monday, December 10, 2018. Persons who
desire to make an oral statement, may request it at the time of the
public comment period on December 12, 2018 at 11:40 a.m., EST.
DATES: The meeting will be held on December 11, 2018, 8:30 a.m. to 4:30
p.m., EST and December 12, 2018, 8:30 a.m. to 12:00 p.m., EST.
ADDRESSES: 8 Corporate Blvd., Building 8, Conference Rooms 1-A/B/C,
Atlanta, Georgia, 30329 and Web conference: 1-877-927-1433 and
participant passcode: 12016435 and https://adobeconnect.cdc.gov/r5p8l2tytpq/.
FOR FURTHER INFORMATION CONTACT: Margie Scott-Cseh, Committee
Management Specialist, CDC, 1600 Clifton Road, NE, Mailstop: E-07,
Atlanta, Georgia, 30333, telephone (404) 639-8317; [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: This Council advises and makes recommendations to the
Secretary of Health and Human Services, the Assistant Secretary for
Health, and the Director, CDC, regarding the elimination of
tuberculosis. Specifically, the Council makes recommendations regarding
policies, strategies, objectives, and priorities; addresses the
development and application of new technologies; and reviews the extent
to which progress has been made toward eliminating tuberculosis.
Matters to be Considered: The agenda will include discussions on
(1) Division of Tuberculosis Elimination (DTBE) funded Demonstration
Project on Latent Tuberculosis Infection (LTBI) Testing and Treatment;
(2) DTBE Communications Messaging and Campaigns; (3) Update on LTBI
Treatment Guidelines; (4) Update on Drug Resistant Tuberculosis
Guidelines; and (5) Update from ACET workgroups. Agenda items are
subject to change as priorities dictate.
The Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2018-23974 Filed 11-1-18; 8:45 am]
BILLING CODE 4163-18-P
